[go: up one dir, main page]

WO2006067600A3 - Herbal formulations as cough lozenge - Google Patents

Herbal formulations as cough lozenge Download PDF

Info

Publication number
WO2006067600A3
WO2006067600A3 PCT/IB2005/003860 IB2005003860W WO2006067600A3 WO 2006067600 A3 WO2006067600 A3 WO 2006067600A3 IB 2005003860 W IB2005003860 W IB 2005003860W WO 2006067600 A3 WO2006067600 A3 WO 2006067600A3
Authority
WO
WIPO (PCT)
Prior art keywords
herbal formulations
formulations
polyherbal
cough lozenge
relates
Prior art date
Application number
PCT/IB2005/003860
Other languages
French (fr)
Other versions
WO2006067600A2 (en
Inventor
Chandra Kant Katiyar
Aravind Padiyar
Rahul Singh
Roopak Kumar
Anil Kanaujia
Navin Kumar Sharma
Original Assignee
Ranbaxy Lab Ltd
Chandra Kant Katiyar
Aravind Padiyar
Rahul Singh
Roopak Kumar
Anil Kanaujia
Navin Kumar Sharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Chandra Kant Katiyar, Aravind Padiyar, Rahul Singh, Roopak Kumar, Anil Kanaujia, Navin Kumar Sharma filed Critical Ranbaxy Lab Ltd
Publication of WO2006067600A2 publication Critical patent/WO2006067600A2/en
Publication of WO2006067600A3 publication Critical patent/WO2006067600A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to polyherbal pharmaceutical formulations in the form of lozenges which have been found to be effective in treating and managing coughs and sore throats. The invention also relates to processes for preparation, detection and quantitative analysis of individual phytochemicals used in the polyherbal formulations.
PCT/IB2005/003860 2004-12-23 2005-12-22 Herbal formulations as cough lozenge WO2006067600A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2550DE2004 2004-12-23
IN2550/DEL/2004 2004-12-23

Publications (2)

Publication Number Publication Date
WO2006067600A2 WO2006067600A2 (en) 2006-06-29
WO2006067600A3 true WO2006067600A3 (en) 2006-08-24

Family

ID=36182116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/003860 WO2006067600A2 (en) 2004-12-23 2005-12-22 Herbal formulations as cough lozenge

Country Status (1)

Country Link
WO (1) WO2006067600A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108697665A (en) * 2015-09-30 2018-10-23 乔治·爱德华·霍格 Topical analgesic pain relief formulations, methods of preparation and use thereof
CN108760947A (en) * 2018-09-05 2018-11-06 翟纹静 The method of a variety of anesthetic in triple level four bars gas chromatography mass spectrometry detection aquatic products

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US4980169A (en) * 1990-05-03 1990-12-25 Warner-Lambert Company Flavor enhancing and increasing efficacy of cough drops
US6541045B1 (en) * 2002-01-04 2003-04-01 Nutraceutical Corporation Herbal composition and method for combating inflammation
US6746694B1 (en) * 2000-10-02 2004-06-08 Council Of Scientific And Industrial Research Herbal composition for treating asthma

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US4980169A (en) * 1990-05-03 1990-12-25 Warner-Lambert Company Flavor enhancing and increasing efficacy of cough drops
US6746694B1 (en) * 2000-10-02 2004-06-08 Council Of Scientific And Industrial Research Herbal composition for treating asthma
US6541045B1 (en) * 2002-01-04 2003-04-01 Nutraceutical Corporation Herbal composition and method for combating inflammation

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
"European Pharmacopoeia 4th Edition", 20 September 2001, EDQM COUNCIL OF EUROPE, STRASSBOURG, FRANCE, XP002382613 *
"European Pharmacopoeia 4th Edition", 20 September 2001, EDQM COUNCIL OF EUROPE, STRASSBOURG, FRANCE, XP002382614 *
ANONYMOUS: "Herbal/Ayurvedic", INTERNET ARTICLE, 31 October 2004 (2004-10-31), XP002382608, Retrieved from the Internet <URL:http://web.archive.org/web/20041031082625/http://www.acgil.com/archive/percos/other_products/branded_herbal001.htm> [retrieved on 20060524] *
ANONYMOUS: "Olbas Pastilles Throat Lozenges", INTERNET ARTICLE, 7 September 2003 (2003-09-07), XP002382855, Retrieved from the Internet <URL:http://web.archive.org/web/20030907164825/http://www.veganessentials.com/catalog/olbas-pastilles-throat-lozenges.htm> [retrieved on 20060524] *
SRIVASTAVA, S., VERMA, R.K., GUPTA, M.M., SINGH, S.C., AND KUMAR, S.: "HPLC determination of vasicine and vasicinone in Adhatoda vasica with photo diode array detection", JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, vol. 24, no. 2, 2001, pages 153 - 159, XP008064712 *

Also Published As

Publication number Publication date
WO2006067600A2 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2006099579A3 (en) Compositions and methods for clonal amplification and analysis of polynucleotides
WO2007059008A3 (en) N-substituted indenoisoquinolines and syntheses thereof
WO2006045119A3 (en) Improved inhibitors for the soluble epoxide hydrolase
WO2007109600A3 (en) Extractions and methods comprising elder species
NO20074753L (en) A pharmaceutical composition for treating depression and method of preparation thereof
WO2005086937A3 (en) Methods and compositions for inhibiting monoamine oxidase and catechol-l-methyltransferase
BRPI0718586A2 (en) COMPOUND, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, USES OF THIS AND METHOD OF TREATMENT OR PREVENTION OF DISEASES
NO20072290L (en) Organic compounds.
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
WO2006076003A3 (en) Vaccinia virus strains
WO2007028151A3 (en) Surgical devices and related methods thereof
EP1845928A4 (en) Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis
WO2010041252A3 (en) Use of a cinnamon bark extract for treating amyloid-associated diseases
CL2008000982A1 (en) COMPOUNDS DERIVED FROM 5-OXO-ISOXAZOL-CARBOXAMIDA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PROCEDURE OF PRODUCTION OF THE PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PREVENTION OF ATEROSCLEROTIC DISORDERS, OF METABOLISM OF
EP2305268A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES CAUSED BY IMPROVEMENTS AND GOLD CROWN EXTRACT
WO2008155390A3 (en) Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases.
WO2007134350A8 (en) Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases
WO2005089310A3 (en) Breath test for oral malodor
WO2006067600A3 (en) Herbal formulations as cough lozenge
BRPI0712478B8 (en) use of plant material or plant material extract
WO2005089294A3 (en) Synthesis of indenoisoquinoliniums and methods of use
WO2005049058A8 (en) Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases
ATE460168T1 (en) NON-RADIOACTIVE STRONTIUM AGENT FOR THE TREATMENT OF CANCER

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05824913

Country of ref document: EP

Kind code of ref document: A2